ZSCAN1 and rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome: In conclusion, we used the sera of patients with ROHHAD syndrome not associated with a tumor and identified ZSCAN1 as a target antigen for autoantibody response.